Research shows that pfizer (PFE.US) Ibrance is expected to treat appendiceal cancer.
Pfizer's breast cancer drug Ibrance has shown promising effects in treating a certain type of appendiceal cancer.
Pfizer Palbociclib Potentially Effective for Certain Types of Appendix Cancer
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Pfizer Options Spot-On: On October 16th, 86,372 Contracts Were Traded, With 3 Million Open Interest
ViiV Reports Positive Real-world Data for HIV Prevention Drug
Novavax Stock Plummets 17% as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
Express News | ViiV Healthcare, Owned By GSK, Pfizer And Shionogi, Announced The Presentation Of New Real-world Evidence And Implementation Data Showing The Effectiveness, Adherence, And Quality-of-life Improvement Of Apretude (Cabotegravir Long-acting) For HIV...
Guggenheim's Work With Two Former Pfizer Executives Strains Relations, FT Says
Why I'm Considering Leaning Heavily Into Pfizer
Pfizer Options Spot-On: On October 15th, 108.53K Contracts Were Traded, With 2.99 Million Open Interest
What to Expect From Pfizer's Q3 2024 Earnings Report
Express News | An Van Gerven Is Appointed President of Pfizer Canada
Pfizer Taps Vanguard Veteran for Board Amid Fight With Starboard
Pfizer, TRIANA Enter Research Collaboration
Pfizer Went From Covid Star to Activist Target After Stock Drop
Express News | Pfizer Inc - Board Now Comprises 14 Directors, 13 Independent
Tim Buckley Elected to Pfizer's Board of Directors
Express News | Tim Buckley Elected to Pfizer’s Board of Directors
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note